The results showed that a higher expression level of BCL2A1 was observed in all cancerous tissues compared with normal tissues and was positively correlated with high-grade and advanced ovarian cancers compared with the level of BCL2A1 in low-grade and early-stage ovarian cancers (Figure 3H). This evidence concerns the gene BCL2A1 and ovarian carcinoma.